Učitavanje...
Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo
Treatment with PPARγ agonists in vivo improves human adipocyte metabolism, but the cellular mechanisms and possible depot differences in responsiveness to their effects are poorly understood. To examine the ex vivo metabolic effects of rosiglitazone (Rosi), we cultured explants of human visceral (om...
Spremljeno u:
| Izdano u: | J Lipid Res |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The American Society for Biochemistry and Molecular Biology
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446708/ https://ncbi.nlm.nih.gov/pubmed/30782959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M091173 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|